Table 5.
Zanamivir pharmacokinetics estimated from one- and two-compartment models using regimen Aa
Model | kel (h−1) | t1/2 (h) | V1 (liter/kg) | CL (liter/kg/h) | V2 (liter/kg) | CL2 (liter/kg/h) | AUC (ng/ml h) | Cmax (ng/ml) | tα1/2 (h) | tβ1/2 (h) |
---|---|---|---|---|---|---|---|---|---|---|
1 Compartment | 0.537 | 1.291 | 0.222 | 0.114 | 108,584 | 6,833 | ||||
0.388 | 0.985 | 0.178 | 0.088 | 94,314 | 5,895 | |||||
0.704 | 1.787 | 0.252 | 0.16 | 145,017 | 9,048 | |||||
2 Compartment | 0.813 | 0.853 | 0.138 | 0.111 | 0.109 | 0.07 | 110,924 | 7,014 | 0.386 | 2.044 |
0.602 | 0.568 | 0.078 | 0.085 | 0.069 | 0.025 | 97,191 | 6,061 | 0.139 | 1.607 | |
1.221 | 1.152 | 0.206 | 0.157 | 0.164 | 0.237 | 150,502 | 9,337 | 0.838 | 4.039 |
Median values are given in the top line of each row, and underneath are the range values. Regimen A, 800 mg zanamivir infused during 16 h. kel, elimination rate constant; t1/2, elimination half life; V1, volume of the central (or only) compartment; CL, clearance from the central (or only) compartment; V2, volume of the second compartment; CL2, intercompartmental clearance; AUC, total area under the concentration-time curve; Cmax, maximum concentration; tα1/2, half life corresponding to the initial elimination phase (in a two-compartment model); tβ1/2, terminal elimination half life.